Oliver Dolan
Vermogen: 242 708 $ op 31-05-2026
Vermogen: 242 708 $ op 31-05-2026
Oliver Dolan currently works at Korro Bio, Inc., as Chief Accounting Officer & Senior VP-Finance from 2025.
Mr. Dolan also formerly worked at Unity Biotechnology, Inc., as Vice President-Accounting, Tax & Treasury from 2020 to 2023.
Mr. Dolan received his undergraduate degree from University College Dublin and Masters Business Admin degree from MIT Sloan School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,13% | 16-06-2026 | 18.099 ( 0,13% ) | 242 708 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Comptroller/Controller/Auditor | 01-12-2023 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University College Dublin
University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unity Biotechnology, Inc.
Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau